Occipital hypoperfusion in Parkinson's disease without dementia: Correlation to impaired cortical visual processing

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 4, 2003, Pages 419-422

  Abe, Y ^a,b   Kachi, T ^a   Kato, T ^c   Arahata, Y ^a   Yamada, T ^a   Washimi, Y ^a   Iwai, K ^a,b   Ito, K ^c   Yanagisawa, N ^d   Sobue, G ^b  

^a CHUBU NATIONAL HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^d KANTO ROSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IOFETAMINE I 123;

AGE; AGED; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; FEMALE; HUMAN; MALE; MOTOR DYSFUNCTION; NEUROPATHOLOGY; OCCIPITAL LOBE; PARIETAL LOBE; PARKINSON DISEASE; PERFUSION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VISUAL IMPAIRMENT;

AGED; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OCCIPITAL LOBE; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VISION DISORDERS; VISUAL CORTEX;

EID: 0037381160     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.4.419     Document Type: Article

References (41)

1. Wolfson LI, Leenders KL, Brown LL, et al. Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease. Neurology 1985;35:1399-405.
2. Defebvre L, Lecouffe P, Destee A, et al. Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease. Acta Neurol Scand 1995;92:235-41.
3. Tachibana H, Kawabata K, Tomino Y, et al. Brain perfusion imaging in Parkinson's disease and Alzheimer's disease demonstrated by three-dimensional surface display with 1231-iodoamphetamine. Dementia 1993;4:334-41.
4. Jagust WJ, Reed BR, Martin EM, et al. Cognitive function and regional cerebral blood flow in Parkinson's disease. Brain 1992;115:521-37.
5. Imon Y, Matsuda H, Ogawa M, et al. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease. J Nucl Med 1999;40:1583-9.
6. Perlmutter JS, Raichle ME. Regional blood flow in hemiparkinsonism. Neurology 1985;35:1127-34.
7. 99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 1991;54:787-92.
8. Wang SJ, Liu RS, Liu HC, et al. Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization. Eur J Nucl Med 1993;20:339-44.
9. Friston KJ, Ashburner J, Frith CD, et al. Spatial registration and normalization of images. Hum Brain Mapp 1995;3:165-89.
10. Friston KJ, Holmes AP, Worsley KJ, et al. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995;2:189-210.
11. 18F-fluorodeoxyglucose positron emission tomography study. Neurology 1997;48:1566-71.
12. Desgranges B, Baron JC, de la Sayette V, et al. The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain 1998;121:611-31.
13. Van Bogaert P, David P, Gillain CA, et al. Perisylvian dysgenesis. Clinical, EEG, MRI and glucose metabolism features in 10 patients. Brain 1998;121:2229-38.
14. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
15. Fahn S, Elton RL, Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, et al, eds. Recent development in Parkinson's disease. Florham Park NJ: MacMillan Healthcare Information, 1987:153-63, 293-304.
16. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
17. Raven J. Guide to using the coloured progressive matrices. London: Lewis, 1965.
18. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;25:638-43.
19. Ogawa K. A practical method for position-dependent compton-scatter correction in single photon emission CT. IEEE Trans Med Imaging 1991;10:408-12.
20. Iida H, Itoh H, Nakazawa M, et al. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J Nucl Med 1994;35:2019-30.
21. Evans AC, Collins DL, Milner B. An MRI-based stereotactic atlas from 250 young normal subjects. Soc Neurosci Abstr 1992;18:408.
22. Bodis-Wollner I, Marx MS, Mitra S, et al. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain 1987;110:1675-98.
23. Haug BA, Kolle RU, Trenkwalder C, et al. Predominant affection of the blue cone pathway in Parkinson's disease. Brain 1995;118:771-8.
24. Lieb K, Brucker S, Bach M, et al. Impairment in preattentive visual processing in patients with Parkinson's disease. Brain 1999;122:303-13.
25. Pirozzolo FJ, Hansch EC, Mortimer JA, et al. Dementia in Parkinson disease: a neuropsychological analysis. Brain Cogn 1982;1:71-83.
26. Boller F, Passafiume D, Keefe NC, et al. Visuospatial impairment in Parkinson's disease. Role of perceptual and motor factors. Arch Neurol 1984;41:485-90.
27. Tanaka F, Kachi T, Yamada T, et al. Auditory and visual event-related potentials and flash visual evoked potentials in Alzheimer's disease: correlations with Mini-Mental State Examination and Raven's coloured progressive matrices. J Neurol Sci 1998;156:83-8.
28. Peppard RF, Martin WR, Carr GD, et al. Cerebral glucose metabolism in Parkinson's disease with and without dementia. Arch Neurol 1992;49:1262-8.
29. Eberling JL, Richardson BC, Reed BR, et al. Cortical glucose metabolism in Parkinson's disease without dementia. Neurobiol Aging 1994;15:329-35.
30. Bohnen NI, Minoshima S, Giordani B, et al. Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia. Neurology 1999;52:541-6.
31. 18FDG-PET study. Brain 2000;123:340-52.
32. Warrington EK, James M, Kinsbourne M. Drawing disability in relation to laterality of cerebral lesion. Brain 1966;89:53-82.
33. Benson DF, Barton MI. Disturbances in constructional ability. Cortex 1970;6:19-46.
34. Ikeda H, Head GM, Ellis CJ. Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study. Vision Res 1994;34:2629-38.
35. Jellinger KA. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 1991;14:153-97.
36. Hughes AJ, Daniel SE, Blankson S, et al. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140-8.
37. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13:266-71.
38. Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 1995;20:91-127.
39. Denny-Brown D, Yanagisawa N, Kirk E. The localization of hemispheric mechanism of visually directed reaching and grasping. In: Zülch KJ, Kreutzfeldt O, Galbraith GC, eds. Cerebral localization. Berlin: Springer, 1975:62-75.
40. Denny-Brown D, Yanagisawa N. The role of the basal ganglia in initiation of movement. In: Yahr M, ed. The basal ganglia. New York: Raven Press, 1976:115-49.
41. Kemp JM, Powell TP. The cortico-striate projection in the monkey. Brain 1970;93:525-46.